[HTML][HTML] Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing
LJ Rojas, M Yasmin, J Benjamino, SM Marshall… - PloS one, 2022 - journals.plos.org
Background Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing.
LJ Rojas, M Yasmin, J Benjamino, SM Marshall… - PLoS …, 2022 - search.ebscohost.com
Background: Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in
many patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
many patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing
LJ Rojas, M Yasmin, J Benjamino, SM Marshall… - 2022 - ri.conicet.gov.ar
Background Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
[HTML][HTML] Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing
LJ Rojas, M Yasmin, J Benjamino, SM Marshall… - PLoS ONE, 2022 - ncbi.nlm.nih.gov
Background Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing.
LJ Rojas, M Yasmin, J Benjamino, SM Marshall… - PLoS …, 2022 - mouseion.jax.org
BACKGROUND: Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in
many patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
many patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: a population-level analysis beyond susceptibility testing.
LJ Rojas, M Yasmin, J Benjamino, SM Marshall… - 2022 - cabidigitallibrary.org
Background: Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in
many patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
many patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing.
LJ Rojas, M Yasmin, J Benjamino, SM Marshall… - PLoS ONE, 2022 - go.gale.com
Background Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing
LJ Rojas, M Yasmin, J Benjamino, SM Marshall… - PloS …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing.
LJ Rojas, M Yasmin, J Benjamino, SM Marshall… - Plos one, 2022 - europepmc.org
Background Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing
LJ Rojas, M Yasmin, J Benjamino, SM Marshall… - PLoS …, 2022 - ui.adsabs.harvard.edu
Background Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …
patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal …